California’s Opioid Settlements

As the opioid overdose epidemic and addiction crisis rage across the United States, state, local, and tribal governments have begun levying lawsuits against pharmaceutical and drug distribution companies. The lawsuits allege that these companies fueled the opioid crisis by marketing opioids in misleading ways, downplaying risks, exaggerating benefits, and engaging in reckless distribution practices. The lawsuits seek to recover costs associated with the opioid overdose epidemic.

California has joined several lawsuits against manufacturers, distributors, and others responsible for aiding the opioid epidemic. In late 2022, cities and counties in California will receive the first round of funding from settlements with opioid manufacturer Janssen Pharmaceuticals (parent company of Johnson & Johnson) and the “big three” distributors, McKesson, AmerisourceBergen, and Cardinal Health (“the Distributors”). It’s estimated that California will receive approximately $2.05 billion from the Janssen and Distributors (J&D) Settlement Agreements over the next 18 years. The vast majority of this money will be provided to cities and counties to be used for opioid abatement activities.

For more information about California’s opioid settlement funds, visit the DHCS website.

Questions on California’s Opioid Settlements

Questions about opioid litigation and participation can be directed to the Office of the Attorney General at

Questions about the OSF and oversight of Participating Subdivisions can be directed to DHCS at

Additional Links